FK866 (APO866, Daporinad),NAMPT抑制剂

FK866 (APO866, Daporinad) (订货以英文为准)

编号:F127321
CAS号:658084-64-1
分子式:C24H29N3O2
分子量:391.51
货号 品牌 包装 目录价 您的价格 库存 数量 购买
F127321-5mg 阿拉丁 5mg ¥529.90
F127321-25mg 阿拉丁 25mg ¥2059.90
F127321-100mg 阿拉丁 100mg ¥5767.90
产品名称 FK866 (APO866, Daporinad)
中文名称 FK866 (APO866, Daporinad),NAMPT抑制剂
CAS号 658084-64-1
MDL编码 MFCD10565943
分子式(M.F.) C24H29N3O2
分子量(M.W.) 391.51
储存条件 -20°C储存
敏感性易吸湿
溶解性Soluble in ethanol (78 mg/ml at 25 °C), DMF (40 mg/ml), DMSO (100 mg/ml), PBS (pH 7.2) (~0.5 mg/ml), and water (<1 mg/ml at 25 °C), DMSO 25mg/ml Ethanol dimethyl formamide
存贮条件储存温度-20°C
应用A highly specific non-competitive inhibitor of NAMPT
产品介绍FK866 (APO866, Daporinad)有效抑制烟酰胺磷酸核糖转移酶(NMPRTase),无细胞试验中IC50为0.09 nM。Phase 1/2。
备注APO866 effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase) with IC50 of 0.09 nM. Phase 1/2.
生化机理FK-866 has been shown to induce apoptosis by non-competitive, and specific inhibition of nicotamide phosphoribosyltransferase (NAMPT). NAMPT is a key regulatory enzyme that mediates NAD+ biosynthesis within cells. Mechanistic studies show that this compound contains an enzymatic active site of visfatin which is optimized for nicotinamide binding and inhibition. Visfatin also contains a similar structure to insulin and mimics its actions by binding to the insulin receptors.
别名(2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺;Daporinad; APO866; FK-866; FK 866; APO 866; APO-866;(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)acrylamide
标识符号https://www.aladdin-e.com/images/ghs/ghs06.jpg
信号词Danger
危害声明H301
警示性声明P301 + P310
WGK德国3
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:86-57-7
¥ 588.00 N814508-100g
CAS号:1314-56-3
¥ 59.90 P116348-100g
¥ 1460.00 LR-HP9015B-1台
CAS号:25322-68-3
¥ 158.00 013685317-25g
CAS号:110-63-4
¥ 62.00 01007907-500mL
¥ 240.00 GBW(E)130035-35g
¥ 1780.00 3123000284-1把
CAS号:78-67-1
¥ 160.00 016546525-25g
CAS号:25322-68-3
¥ 178.00 60304ES76-500g